Astria Therapeutics, Inc. (ATXS)
12.84
-0.08
(-0.58%)
USD |
NASDAQ |
Dec 16, 12:17
Astria Therapeutics Research and Development Expense (TTM): 98.04M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| BioCryst Pharmaceuticals, Inc. | 173.40M |
| Johnson & Johnson | 15.77B |
| Alnylam Pharmaceuticals, Inc. | 1.248B |
| CorMedix, Inc. | 12.46M |
| Rezolute, Inc. | 61.92M |